Immunovia AB (OTCPK:IMMVF)
$ 0.07382 0 (0%) Market Cap: 8.20 Mil Enterprise Value: 3.48 Mil PE Ratio: 0 PB Ratio: 2.76 GF Score: 49/100

Q2 2024 Immunovia AB (publ) Earnings Call Transcript

Aug 05, 2024 / 01:00PM GMT
Release Date Price: $0.073824
Karin Liwendahl;publ;Chief Financial Officer
Immunovia AB

()-

Good morning and good afternoon to you all, and welcome to this conference call following the Immunovia second quarter results. Presenting on this call is Jeff Borcherding, CEO of Immunovia; and myself, Karin Almqvist, CFO of the company. (Event Instructions) After we have closed today's call, you will find the presentation and recording on our website. And having said that, I would very much like to hand over to our CEO. Jeff, please.

Jeff Borcherding;publ;President;Chief Executive Officer
Immunovia AB

()-&

Thanks very much, Karen, and I appreciate it, and thank you all for joining us today. I'm incredibly excited to share the results that we have delivered in the second quarter, both as a company as well as the performance that we're going to talk about with our next generation tests.

We have been working very, very hard over the last year to transform the company into a much leaner, more agile company

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot